文献速递肾癌与肾肿瘤

经皮核心穿刺活检预测肾肿瘤病理的系统综述

Performance of percutaneous core biopsy in predicting renal tumour pathology: a systematic review.
PubMed 文献 · BJU Int · 2025-11-21

结果显示活检检测恶性的加权平均敏感度为98%(95%CI 0.96-1.00),特异度为94%(95%CI 0.84-1.00),汇总ROC曲线下面积为0.97。作者认为排除活检不会改变管理的患者后,近乎常规的肾肿瘤活检可能减少最终为良性肿瘤的肾切除术率并优化手术室利用。

要点

  • 肾肿瘤核心穿刺活检检测恶性的敏感度98%、特异度94%,诊断准确性高。
  • 首次活检非诊断率8%,第二次活检非诊断率9%。
  • 肿瘤亚型一致率92%,Fuhrmann分级精确一致率60%,简化低/高级别一致率79%。

核心结论

  • 成人肾肿块核心穿刺活检检测恶性具有高敏感度和特异度。
  • 排除活检不会改变管理的患者后,近乎常规的肾肿瘤活检可能减少最终为良性肿瘤的肾切除术率并优化手术室利用。

研究设计与样本

  • 系统综述,检索Cochrane、Embase、Medline数据库及灰色文献至2024年9月。

主要发现

  • 检测恶性的加权平均敏感度为98%(95%CI 0.96-1.00),特异度为94%(95%CI 0.84-1.00)。
  • 平均假阳性率6%,假阴性率2%。
  • 首次活检非诊断率8%,第二次活检尝试非诊断率9%。
  • 肿瘤亚型一致率92%,Fuhrmann分级精确一致率60%,简化低/高级别一致率79%。
  • 汇总ROC曲线分析显示检测准确性高(曲线下面积0.97)。

临床怎么用

  • 对活检不会改变管理的患者除外,可考虑近乎常规的肾肿瘤活检以减少良性肿瘤的肾切除术。
  • 活检结果可辅助优化手术室利用。

局限性

  • 多数研究偏倚风险为中至高度。
  • 纳入研究均为非随机队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To systematically assess the diagnostic accuracy of renal tumour core biopsy for detecting malignancy in adults with localised renal masses. MATERIALS AND METHODS: A search of the Cochrane, Embase and Medline databases and the grey literature published up to September 2024 was performed using pre-published methods. Eligible studies were published in English, reported all true- and false-positive and -negative results for localised renal tumour core biopsies in unique adult cohorts, and used surgical histology as the reference standard. Studies were excluded if they exclusively reported patients with malignant biopsy or surgical histology. Primary outcomes were biopsy sensitivity and specificity for detecting malignancy. RESULTS: Twenty-one non-randomised cohorts were identified, totalling 1735 unique patients. In detecting malignancy, renal tumour core biopsy had a weighted mean sensitivity of 98% (95% confidence interval [CI] 0.96-1.00) and specificity of 94% (95% CI 0.84-1.00). Secondary outcomes were determined, including mean false-positive rate (6%), false-negative rate (2%), non-diagnostic rate on first (8%) and second biopsy attempt (9%), and concordance of tumour sub-type (92%) and Fuhrmann grade, both exact grade (60%) and simplified low/high grade (79%). Summary receiver-operating characteristic curve analysis demonstrated high test accuracy (area under the curve 0.97). Risk of bias was moderate to high for most studies. CONCLUSION: Core biopsy for renal masses in adults has high specificity and sensitivity. Excluding patients for whom biopsy will not change management, near-routine renal tumour biopsy may reduce rates of nephrectomy for ultimately benign tumours, and optimise operating theatre utilisation.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Stokes R, Hennessey D, Kinnear N, et al. Performance of percutaneous core biopsy in predicting renal tumour pathology: a systematic review. BJU Int. 2025. PMID: 41269070. doi:10.1111/bju.70045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。